Peter Switzer of the Switzer Super Report has canvassed market experts to draw up a list of top FY19 stock picks.
Stockbrokers are still not keen on buying Sigma Healthcare shares, though a capital return might change their view.
Michael Gable of Fairmont Equities notes Seven Group Holdings has retreated sharply after a long, strong run.
Weebit Nano is set to significantly increase memory chip capacity while reducing size and temperature and increasing longevity.
In the third part of his series on climate change, Ahead of the Herd’s Rick Mills examines the collapse of world fish stocks.
Australian regulators are cracking down on “one-stop shop” investment advisors to SMSFs, claiming bad advice.
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.
Craig Parker of Moat Capital sees more consolidation ahead for the ASX200, dependent on how long the local market remains at arm’s length from international issues.
Aurizon has re-confirmed FY18 guidance but signalled a deteriorating outlook for FY19. Broker attitudes vary widely, given the regulatory uncertainties hanging over the stock.
Aerial imaging company Nearmap is drawing attention from brokers, who are excited about the company’s US growth prospects.
